Back to top
more

bluebird bio (BLUE)

(Delayed Data from NSDQ)

$0.90 USD

0.90
4,172,836

+0.01 (0.87%)

Updated May 31, 2024 04:00 PM ET

After-Market: $0.90 0.00 (-0.38%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (88 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for BLUE

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

bluebird bio, Inc. [BLUE]

Reports for Purchase

Showing records 321 - 340 ( 532 total )

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 321

05/26/2017

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of May 29

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 322

05/24/2017

Daily Note

Pages: 3

Corrected - Coverage Update - Healthcare

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 323

05/24/2017

Daily Note

Pages: 3

Coverage Update - Healthcare

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 324

05/24/2017

Company Report

Pages: 4

We are dropping coverage of BLUE shares to reallocate our research resources

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 325

05/19/2017

Industry Report

Pages: 6

EHA Abstract Roundup

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 326

05/18/2017

Industry Report

Pages: 7

ASCO 2017 Abstract Roundup and Schedule for Covered Companies

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 327

05/04/2017

Company Report

Pages: 6

Q1 Financials; Data Rich Year Ahead; Alignment with EMA on LentiGlobin Pathway; Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 328

04/28/2017

Daily Note

Pages: 6

The Week Ahead in Life Sciences - Upcoming Events for the Week of May 1

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 329

04/21/2017

Industry Report

Pages: 6

The Week Ahead in Life Sciences: Upcoming Events for the Week of April 24

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 330

04/13/2017

Industry Report

Pages: 5

The Week Ahead in Life Sciences: Upcoming Events for the Week of April 17

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 331

04/07/2017

Industry Report

Pages: 5

The Week Ahead in Life Sciences Upcoming Events for the Week of April 10.

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 332

04/06/2017

Industry Report

Pages: 13

Healthcare - Cancer in Washington: 2017 AACR Highlights

Provider: Roth Capital Partners, Inc.

Analyst: BREIDENBACH M

Price: 50.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 333

04/06/2017

Industry Report

Pages: 13

Healthcare - Cancer in Washington: 2017 AACR Highlights

Provider: Roth Capital Partners, Inc.

Analyst: BREIDENBACH M

Price: 50.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 334

03/31/2017

Industry Report

Pages: 6

The Week Ahead in Life Sciences - Upcoming Events for the Week of April 3

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 335

03/24/2017

Industry Report

Pages: 5

The Week Ahead in Life Sciences: Upcoming Events for the Week of March 27

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 336

02/24/2017

Industry Report

Pages: 5

The Week Ahead in Life Sciences: Upcoming Events for the Week of Feb 27

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 10.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 337

02/23/2017

Company Report

Pages: 8

Incremental Progress Expected in 2017; Remaining on Sidelines

Provider: Roth Capital Partners, Inc.

Analyst: BREIDENBACH M

Price: 25.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 338

02/23/2017

Daily Note

Pages: 4

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 339

02/23/2017

Company Report

Pages: 8

Incremental Progress Expected in 2017- Remaining on Sidelines.

Provider: Roth Capital Partners, Inc.

Analyst: BREIDENBACH M

Price: 25.00

Research Provided by a Third Party

Company: bluebird bio, Inc.

Industry: Medical - Biomedical and Genetics

Record: 340

02/22/2017

Company Report

Pages: 7

4Q/FY16, First Look at Improved LentiGlobin and Updates from bb2121 Program Expected in June, Reiterate OP

Provider: WEDBUSH SECURITIES INC.

Analyst: NIERENGARTEN D

Price: 25.00

Research Provided by a Third Party